Although the number of low BMI patients in the RRMS group was relatively low (n = 10), the finding that low BMI patients differ significantly from the other subjects was calculated based on the entire group of controls (n = 89) and patients (n = 36 RRMS, n = 25 progressive MS), and the statistical model predicting the effect observed in the group of RRMS patients was highly significant.
← all excerpts
Relapsing-remitting multiple sclerosis patients display an altered lipoprotein profile with dysfunctional HDL.
1
—
—